δ-Secretase-cleaved Tau stimulates Aβ production via upregulating STAT1-BACE1 signaling in Alzheimer’s disease

[1]  Paul Edison,et al.  Neuroinflammation in Alzheimer's disease: Current evidence and future directions , 2016, Alzheimer's & Dementia.

[2]  J. Hardy,et al.  The amyloid hypothesis of Alzheimer's disease at 25 years , 2016, EMBO molecular medicine.

[3]  A. Levey,et al.  Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease , 2015, Nature Communications.

[4]  M. Lynch,et al.  Inhibition of JAK2 attenuates the increase in inflammatory markers in microglia from APP/PS1 mice , 2015, Neurobiology of Aging.

[5]  D. Holtzman,et al.  Three dimensions of the amyloid hypothesis: time, space and 'wingmen' , 2015, Nature Neuroscience.

[6]  O. Garaschuk,et al.  Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.

[7]  G. Parry,et al.  Human secreted tau increases amyloid-beta production , 2015, Neurobiology of Aging.

[8]  William T. Hu,et al.  Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer’s disease , 2014, Nature Medicine.

[9]  D. Drachman.  The amyloid hypothesis, time to move on: Amyloid is the downstream result, not cause, of Alzheimer's disease , 2014, Alzheimer's & Dementia.

[10]  K. Blennow,et al.  Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid , 2013, Acta Neuropathologica.

[11]  I. Grundke‐Iqbal,et al.  Activation of Asparaginyl Endopeptidase Leads to Tau Hyperphosphorylation in Alzheimer Disease* , 2013, The Journal of Biological Chemistry.

[12]  Jingxia Wu,et al.  Amyloid-β Induces Hepatic Insulin Resistance In Vivo via JAK2 , 2013, Diabetes.

[13]  Huaxi Xu,et al.  Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy , 2013, Nature Reviews Neurology.

[14]  H. Nilsen,et al.  Intra- and extracellular regulation of activity and processing of legumain by cystatin E/M. , 2012, Biochimie.

[15]  V. Laporte,et al.  Lack of tau proteins rescues neuronal cell death and decreases amyloidogenic processing of APP in APP/PS1 mice. , 2012, The American journal of pathology.

[16]  R. Brookmeyer,et al.  Alzheimer disease pathology and longitudinal cognitive performance in the oldest-old with no dementia , 2012, Neurology.

[17]  S. Nam,et al.  Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models , 2012, Journal of Neuroinflammation.

[18]  A. Hebrank,et al.  β-Amyloid burden in healthy aging , 2012, Neurology.

[19]  J. Hong,et al.  Inhibitory effect of a tyrosine-fructose Maillard reaction product, 2,4-bis(p-hydroxyphenyl)-2-butenal on amyloid-β generation and inflammatory reactions via inhibition of NF-κB and STAT3 activation in cultured astrocytes and microglial BV-2 cells , 2011, Journal of Neuroinflammation.

[20]  B. Strooper,et al.  The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics , 2011, Nature Reviews Drug Discovery.

[21]  J. Morris,et al.  Alzheimer’s Disease: The Challenge of the Second Century , 2011, Science Translational Medicine.

[22]  D. Selkoe,et al.  Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration , 2011, Proceedings of the National Academy of Sciences.

[23]  Todd E. Golde,et al.  Anti-Aβ Therapeutics in Alzheimer's Disease: The Need for a Paradigm Shift , 2011, Neuron.

[24]  D. Alkon,et al.  PKC ε Activation Prevents Synaptic Loss, Aβ Elevation, and Cognitive Deficits in Alzheimer's Disease Transgenic Mice , 2011, The Journal of Neuroscience.

[25]  M. Shamloo,et al.  The Asparaginyl Endopeptidase Legumain after Experimental Stroke , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[26]  T. Chiu,et al.  A novel defense mechanism that is activated on amyloid-β insult to mediate cell survival: role of SGK1-STAT1/STAT2 signaling , 2009, Cell Death and Differentiation.

[27]  I. Mook‐Jung,et al.  Constitutive JAK2/STAT1 activation regulates endogenous BACE1 expression in neurons. , 2009, Biochemical and biophysical research communications.

[28]  Charles D. Smith,et al.  Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease , 2009, Neurobiology of Aging.

[29]  Zhixue Liu,et al.  Neuroprotective actions of PIKE-L by inhibition of SET proteolytic degradation by asparagine endopeptidase. , 2008, Molecular cell.

[30]  J. Bibb.  Faculty Opinions recommendation of Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing. , 2008 .

[31]  Bryan Maloney,et al.  Transcriptional Regulation of β-Secretase by p25/cdk5 Leads to Enhanced Amyloidogenic Processing , 2008, Neuron.

[32]  C. Rowe,et al.  Imaging β-amyloid burden in aging and dementia , 2007, Neurology.

[33]  Michael T. Heneka,et al.  Inflammatory processes in Alzheimer's disease , 2007, Journal of Neuroimmunology.

[34]  Y. S. Kim,et al.  IFN‐γ‐induced BACE1 expression is mediated by activation of JAK2 and ERK1/2 signaling pathways and direct binding of STAT1 to BACE1 promoter in astrocytes , 2007, Glia.

[35]  M. Gallagher,et al.  A specific amyloid-β protein assembly in the brain impairs memory , 2006, Nature.

[36]  I. Ferrer,et al.  Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice , 2005, Neurobiology of Disease.

[37]  G. Perry,et al.  β‐Site APP cleaving enzyme up‐regulation induced by 4‐hydroxynonenal is mediated by stress‐activated protein kinases pathways , 2005, Journal of neurochemistry.

[38]  T. Bayer,et al.  A modified β‐amyloid hypothesis: intraneuronal accumulation of the β‐amyloid peptide – the first step of a fatal cascade , 2004, Journal of neurochemistry.

[39]  T. Ohm,et al.  Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology , 2004, Neurobiology of Aging.

[40]  K. Shuai,et al.  Regulation of JAK–STAT signalling in the immune system , 2003, Nature Reviews Immunology.

[41]  Thomas Klockgether,et al.  Nonsteroidal Anti-Inflammatory Drugs and Peroxisome Proliferator-Activated Receptor-γ Agonists Modulate Immunostimulated Processing of Amyloid Precursor Protein through Regulation of β-Secretase , 2003, The Journal of Neuroscience.

[42]  C. Watts,et al.  Multistep Autoactivation of Asparaginyl Endopeptidase in Vitro and in Vivo* , 2003, Journal of Biological Chemistry.

[43]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[44]  F. Schmitt,et al.  Alzheimer neuropathologic alterations in aged cognitively normal subjects. , 1999, Journal of neuropathology and experimental neurology.

[45]  A. Barrett,et al.  Cloning and expression of mouse legumain, a lysosomal endopeptidase. , 1998, The Biochemical journal.

[46]  N. Rawlings,et al.  Cloning, Isolation, and Characterization of Mammalian Legumain, an Asparaginyl Endopeptidase* , 1997, The Journal of Biological Chemistry.

[47]  H. Braak,et al.  Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.

[48]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[49]  D. Campion,et al.  APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy , 2006, Nature Genetics.